Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Quest Diagnostics Inc (DGX)  
$138.19 0.72 (0.52%) as of 4:30 Wed 5/29


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 134,770,000
Market Cap: 18.62(B)
Last Volume: 986,770 Avg Vol: 1,172,393
52 Week Range: $120.62 - $144.92
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  724
Guru Rank Value     : 1.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 8,558 18,097 18,097 100,860
Total Sell Value $1,102,133 $2,309,019 $2,309,019 $14,306,288
Total People Sold 3 4 4 6
Total Sell Transactions 3 7 7 21
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 1541
  Page 13 of 62  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2020-05-18 4 D $107.42 $537 D/D (5) 25,035     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2020-04-27 4 AS $110.00 $555,075 D/D (5,000) 22,390 -6%     
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-04-27 4 AS $112.01 $1,312,433 D/D (11,717) 237,747 -6%     
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-04-27 4 OE $71.17 $833,899 D/D 11,717 249,464     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2020-03-16 4 AS $85.59 $308,251 D/D (3,513) 38,086 45%     
   Lassiter Wright Iii Director   –       •      –    2020-03-12 4 A $0.00 $0 D/D 351 351     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2020-03-11 4 AS $104.25 $260,729 D/D (2,501) 68,411 29%     
   Prevoznik Michael E SVP & General Counsel   •       –      –    2020-03-11 4 AS $104.25 $226,744 D/D (2,175) 40,087 29%     
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2020-03-10 4 D $106.46 $267,960 D/D (2,517) 27,390     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2020-03-10 4 A $106.46 $534,216 D/D 5,018 29,907     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2020-03-10 4 D $106.46 $412,000 D/D (3,870) 73,579     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2020-03-10 4 A $106.46 $818,997 D/D 7,693 77,449     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-03-10 4 AS $112.19 $11,219 D/D (100) 237,747 19%     
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-03-10 4 OE $71.17 $7,117 D/D 100 237,847     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-03-10 4 D $106.46 $1,479,581 D/D (13,898) 237,747     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-03-10 4 A $106.46 $2,670,549 D/D 25,085 251,645     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2020-03-10 4 D $106.46 $29,489 D/D (277) 24,977     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2020-03-10 4 A $106.46 $89,107 D/D 837 25,253     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2020-03-10 4 D $106.46 $409,445 D/D (3,846) 41,599     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2020-03-10 4 A $106.46 $783,439 D/D 7,359 45,445     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2020-03-10 4 D $106.46 $267,960 D/D (2,517) 70,912     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2020-03-10 4 A $106.46 $534,216 D/D 5,018 73,429     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2020-03-10 4 D $106.46 $231,444 D/D (2,174) 42,262     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2020-03-10 4 A $106.46 $462,995 D/D 4,349 44,436     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-03-06 4 AS $112.21 $25,934,978 D/D (230,178) 226,560 7%     

  1541 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 62
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed